ISAKOS: 2023 Congress in Boston, MA USA

2023 ISAKOS Biennial Congress ePoster

 

Costal Chondrocyte-Derived Pellet-Type Scaffold-Free Autologous Chondrocyte Implantation For Osteochondral Defects With Up To 10-Mm Depths

Kyoung-Ho Yoon, MD, PhD, Prof., Seoul KOREA, REPUBLIC OF
Hee Sung Lee, MD, Seoul KOREA, REPUBLIC OF
Cheol Hee Park, MD, PhD, Seoul KOREA, REPUBLIC OF
Sung Hyun Hwang, MD, Seoul KOREA, REPUBLIC OF

Kyung Hee University, Seoul, KOREA, REPUBLIC OF

The FDA has not cleared the following pharmaceuticals and/or medical device for the use described in this presentation. The following pharmaceuticals and/or medical device are being discussed for an off-label use: Biosolution, Cartilife (Phase 2 clinical trial)

Summary

CCP-ACI provided satisfactory mid-term outcomes in OCDs up to 10-mm depths without bone grafting despite of no scaffold or covering membranes.

ePosters will be available shortly before Congress

Abstract

Purpose

To evaluate clinical, radiographic, and magnetic resonance (MR) results of costal chondrocyte-derived pellet-type scaffold-free autologous chondrocyte implantation (CCP-ACI) in osteochondral defects (OCDs) up to 10-mm depths during 5 years of follow-up.

Methods

Ten cases with CCP-ACI performed in OCDs with depths up to 10 mm were retrospectively analyzed. The minimum follow-up period was 5 years. All data were collected prospectively because the cases were involved in a clinical trial. The mean age was 36.5 years. The average size and depth of OCD lesion were 3.83 cm2 and 7.1 mm, respectively. Clinically, the International Knee Documentation Committee, Lysholm, and visual analog scale pain scores were evaluated. Radiographically, the hip?knee?ankle (HKA) angle and the Kellgren?Lawrence (K?L) grade were assessed. On imaging, the magnetic resonance observation of cartilage repair tissue (MOCART) 2.0 score and defect depth were evaluated.

Results

All average clinical scores improved significantly by 1, 2, and 5 years postoperatively. The average HKA angle and the proportion of K?L grade did not change significantly within 5 years (p = 0.758 and 0.200, respectively). The median total MOCART scores were 50, 50, 57.5, and 65 at 6 months, 1 year, 2 years, and 5 years postoperatively, respectively (p = 0.001), with significant improvement at 2 years compared to that at 6 months postoperatively. The signal intensity of the repair tissue and subchondral change significantly improved from 10 to 12.5 (p = 0.036), and from 10 to 17.5 (p = 0.017), respectively. Significant improvements were seen at 5 years postoperatively for the former and at 2 years postoperatively for the latter. The average depths on MR imaging were 6.7, 6.7, 6.8, 6.6, and 6.6 mm preoperatively and at 6 months, 1 year, 2 years, and 5 years postoperatively with no significant changes (p = 0.441)

Conclusion

CCP-ACI provided satisfactory mid-term outcomes in OCDs up to 10-mm depths without bone grafting despite of no scaffold or covering membranes.